Effects of a Structured Education Program on Blood Pressure in Essential Hypertensive Patients
herzleben
1 other identifier
interventional
256
1 country
1
Brief Summary
The purpose of this study is to evaluate the effects of a structured educational program for hypertensive patients. The program was developed at the University of Dusseldorf, Germany. The contents of the program are as follows: teaching of the background of hypertension, techniques of self estimation of blood pressure, life style and dietary habits, some information concerning the different pharmacological properties to treat hypertension
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Mar 2007
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
March 27, 2007
CompletedFirst Posted
Study publicly available on registry
March 28, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJanuary 17, 2011
January 1, 2011
3.3 years
March 27, 2007
January 14, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure at 6 and 12 months of follow up following the educational process
1 year
Secondary Outcomes (1)
morbidity on different cardiovascular and cerebrovascular diseases
1 year
Study Arms (2)
group I (early intervention)
ACTIVE COMPARATORWe refer to the results of the DAFNE-study. This study showed the merits of an educational program in diabetics. In accordance to the protocol of DAFNE, we developed a design as follows: For each participating center patients are randomly assigned to two groups. Group I receives an early educational intervention at time of randomization, which should lead to better control of blood pressure after 6 months compared to the control group. The protocol design was chosen for proving an independent effect of the educational program despite optimal management by the GP. Group II is designated to receive the educational intervention 6 months after enrollment into the study. for further details please see brief description section
delayed education
OTHERdelayed educational intervention for further details please see brief description section
Interventions
structured education and evaluation of hypertensive patients in a design similar to the DAFNE study design. Behavioural intervention follows the Dusseldorf-educational program
Control group consisting of patients randomly assigned to participate in the educational program 6 months later than the active group
Eligibility Criteria
You may qualify if:
- Intellectual and physical ability to attend teaching program,
- Capability to do and document blood pressure self-measurement,
- Systolic blood pressure \>160 and/or diastolic blood pressure \>95 mmHg,
- At least 3 months of preexisting medicamentous anti-hypertensive treatment,
- % or higher risc in New Zealand Risc Scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University Graz
Graz, Styria, A-8036, Austria
Related Publications (1)
Perl S, Niederl E, Kos C, Mrak P, Ederer H, Rakovac I, Beck P, Kraler E, Stoff I, Klima G, Pieske BM, Pieber TR, Zweiker R. Randomized Evaluation of the Effectiveness of a Structured Educational Program for Patients With Essential Hypertension. Am J Hypertens. 2016 Jul;29(7):866-72. doi: 10.1093/ajh/hpv186. Epub 2015 Dec 7.
PMID: 26643687DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Zweiker, MD AssocProf
Medical University Graz Dep of Internal Medicine; Div of Cardiology
- PRINCIPAL INVESTIGATOR
Thomas R Pieber, MD AssocProf
Medical University Graz Dept of Internal Medicine Div of Diabetology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 27, 2007
First Posted
March 28, 2007
Study Start
March 1, 2007
Primary Completion
June 1, 2010
Study Completion
December 1, 2010
Last Updated
January 17, 2011
Record last verified: 2011-01